E
Bionano Genomics, Inc. BNGO
$1.85 $0.042.21% NASDAQ
Recommendation
Prev Close
$1.85
Volume
202,450
Avg Vol (90D)
556,354
Market Cap
$18.83M
Dividend & Yield
--
52-Week Range
$1.45 - $22.80
P/E (TTM)
--
EPS (TTM)
-$16.96
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Bionano Genomics price target lowered by $4 at H.C. Wainwright, here's why
11/24/2025 - The Fly
Bionano Genomics, Inc. (NASDAQ:BNGO) Q3 2025 Earnings Call Transcript
11/14/2025 - Insider Monkey
Bionano Genomics, Inc. 2025 Q3 - Results - Earnings Call Presentation
11/14/2025 - SeekingAlpha
Bionano Genomics Inc (BNGO) Q3 2025 Earnings Call Highlights: Revenue Surge and Strategic Cost ...
11/14/2025 - GuruFocus
Q3 2025 Bionano Genomics Inc Earnings Call Transcript
11/14/2025 - GuruFocus
Bionano Genomics, Inc. (BNGO) Q3 2025 Earnings Call Transcript
11/14/2025 - SeekingAlpha
Bionano Genomics, Inc. (BNGO) Q3 2025 Earnings Call Transcript
11/14/2025 - Seeking Alpha: Transcripts
Bionano Reports Third Quarter 2025 Results and Highlights Recent Business Progress
11/13/2025 - Globe Newswire
iBio, Inc. (IBIO) Reports Q1 Loss
11/12/2025 - Zacks Investment Research
Earnings To Watch: Bionano Genomics Inc (BNGO) Reports Q3 2025 Result
11/12/2025 - GuruFocus
Bionano Genomics (BNGO) Study Highlights Advances in Leukemia Detection
11/6/2025 - GuruFocus
Bionano Genomics announces publication of study on OGM
11/6/2025 - The Fly
Bionano Announces Publication Showing OGM Can Overcome Key Limitations of Targeted RNA-Seq for Cytogenetic Investigation in Acute Leukemia
11/6/2025 - Globe Newswire
Keros Therapeutics, Inc. (KROS) Reports Q3 Loss, Tops Revenue Estimates
11/5/2025 - Zacks Investment Research
Exelixis (EXEL) Beats Q3 Earnings and Revenue Estimates
11/4/2025 - Zacks Investment Research
Bionano to Report Third Quarter 2025 Financial Results and Host a Conference Call Webcast on November 13, 2025
10/30/2025 - Globe Newswire
Bionano Highlights Global Momentum Behind OGM at the 2025 Annual Meeting of the American Society of Human Genetics (ASHG) Meeting
10/23/2025 - Globe Newswire
Bionano Genomics, Inc. (NASDAQ:BNGO) Short Interest Update
10/21/2025 - Ticker Report
Bionano Genomics participates in a conference call with H.C. Wainwright
10/15/2025 - TipRanks Financial Blog
Bionano Genomics participates in a conference call with H.C. Wainwright
10/15/2025 - The Fly
Bionano to Participate in the H.C. Wainwright @ Home Event
10/7/2025 - Globe Newswire
Bionano Genomics Launches $10 Million Public Offering
9/21/2025 - Yahoo! Finance: News
12 Best Fundamentally Strong Penny Stocks to Buy Right Now
9/20/2025 - Insider Monkey
Bionano Genomics, Inc. Announces Closing of $10 Million Public O?ering
9/17/2025 - GuruFocus
Bionano Genomics, Inc. Announces Closing of $10 Million Public O ering
9/17/2025 - Globe Newswire
Income Statement
Total Revenue (TTM)
$28.72M
EBITDA (TTM)
-$16.13M
EBIT (TTM)
-$25.72M
Net Income (TTM)
-$38.59M
Balance Sheet
Total Assets (Q)
$79.06M
Total Debt (Q)
$17.20M
Total Liabilities (Q)
$29.26M
Book Value Per Share (Q)
$5.12
Cash Flow
Cash from Operations (TTM)
-$18.67M
Cash from Investing (TTM)
-$13.76M
Cash from Financing (TTM)
$26.33M
Net Change in Cash (TTM)
-$6.13M
Filings
Filing Date
Thursday, November 13, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
End of March (est)
Price History
Loading...
Beta
1.80
7-Day Total Return
20.13%
30-Day Total Return
-2.63%
60-Day Total Return
-53.63%
90-Day Total Return
-46.53%
Year to Date Total Return
-87.92%
1-Year Total Return
-87.94%
2-Year Total Return
-98.05%
3-Year Total Return
-99.84%
5-Year Total Return
-99.37%
52-week Low
Nov 17, 2025 - $1.45
52-week High
Jan 03, 2025 - $22.80
Valuation
Market Cap
$18.83M - Nano Cap
Enterprise Value
$14.44M
Price/Sales (TTM)
0.34
Price/Book (Q)
0.36
Dividends and Shares
Shares Outstanding
5.34
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
bionano.com
Phone Number
858 888 7600
Address
9540 Towne Centre Drive
San Diego, CA 92121
Country
United States
Year Founded
2003
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Bionano Genomics, Inc., together with its subsidiaries, provides genome analysis solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers genome... more
NASDAQ 11/28/2025 1:00PM Eastern Quotes delayed